TGA · AHPRA · FSANZ · ACCC · Last reviewed: November 2026

    Advertising compliance is no longer the roadblock in Australian health marketing

    20 November 2026 · 6 min read
    Summary

    Advertising compliance earns its reputation as a bottleneck only when it happens last. Moved to before you publish, inside the workflow you already run, it stops being the step that holds a campaign back. This piece covers three set-ups — an in-house team, an external agency and a done-for-you partner — and the three questions each should be able to answer.

    Most health-brand marketers know the moment. The campaign is built, the assets are signed off, and the only thing left is the compliance check. It is meant to be a formality. Instead it is where the calendar slips — a flag here, a rewrite there, a second look that reopens the first. The launch that was timed to a seasonal window lands after it. The cost is rarely a fine. It is the campaign that shipped late and the creative hours spent on rounds instead of on the next idea.

    That reputation is earned, but it is misplaced. Compliance is not the roadblock. The roadblock is when the review happens — at the end, on near-final work, by whoever happens to own it. The TGA acted on thousands of non-compliant ads last year, with 4,806 advertising removal requests issued in 2023/24, so the obligation is real and it is enforced. But meeting it does not have to be the thing that holds a campaign back. Move the check earlier and it becomes a confirmation rather than a negotiation. Where it sits depends on who runs your marketing.

    The question isn't whether to review, it's where

    Every health brand reviews its marketing against the Code somehow, even if "somehow" is a founder reading copy on a Friday afternoon. The difference between a set-up that slows you down and one that doesn't comes down to three questions, and they are the same three whoever does the work:

    • Who checks each claim against the product's ARTG entry before it goes live?
    • Who keeps the record of what was reviewed, and when?
    • What happens when a piece is flagged high risk — who decides, and how fast?

    Hold your own set-up against those three. The gaps tend to show up in the same places.

    If you run it in-house

    An in-house team has the context. They know the product, the ARTG entry and the brand. The gap is usually structure. Claim-checking lives in one person's head, the record is a thread of email approvals nobody can find six months later, and "high risk" has no owner — so a flagged piece either stalls while someone works out who decides, or it ships because the deadline won. Build the three answers in and an in-house team is the fastest set-up there is. Leave them implicit and it is the one most exposed if a claim is ever questioned.

    If an external agency runs it

    A good agency moves quickly and brings craft. What most do not bring is regulatory capability — and in law that matters, because the advertiser carries responsibility for the claim regardless of who wrote it. The common pattern is that the agency creates the content and hands the regulatory check back to the brand, often late and often without the ARTG cross-reference done. So the brand ends up reviewing the agency's work under time pressure, which is the slow sequence again with an extra handoff in it. Put the three questions to any agency you work with, and add a fourth: do you review against the Code before you send it to us, or do you expect us to?

    If a done-for-you partner runs it

    Some brands would rather hand marketing over entirely. A done-for-you partner runs the campaigns end to end, which only removes the compliance bottleneck if the review is built into how they work rather than bolted on at your end. If you'd rather have marketing run for you with compliance built in, ClickFlow — our sister business — is one such partner working with complementary-medicine brands. It is one option among several, and the test is the same: put the three questions to any partner you are considering before you sign.

    How CompliGUARD fits whichever set-up you run

    CompliGUARD is compliance infrastructure that reviews marketing content against TGA · AHPRA · FSANZ · ACCC before it is published. It reads the whole piece the way a regulator does — the overall impression, not isolated keywords — checks claims against the product's registered indications, grades the risk as low, medium or high, cites the specific clause behind every flag, and offers a compliant rewrite that keeps the marketing intent. Each review is logged and timestamped in the Audit Vault as evidence of due diligence. It is built to sit inside whichever set-up above you run: an in-house team uses it to make the check a standing step, and an agency or done-for-you partner uses it so the work reaches you already clean. It does not replace legal or regulatory advice. It is the layer that makes the review happen early, every time.

    Frequently asked questions

    If my agency makes the content, do I still need a compliance review?

    Yes. In law the advertiser is responsible for the claim, not the agency that wrote it. Whoever creates the content, the obligation to meet the Code stays with the brand, so the review has to happen before publish regardless of who holds the pen.

    Who's responsible if non-compliant content is published?

    The advertiser — the brand whose product is promoted. That is why the three questions matter wherever the work is done: an agency or partner can carry the task, but the responsibility sits with you.

    Does building in a review slow the campaign down?

    The opposite, when it is done early. The delay comes from reviewing near-final work and reworking it. A check at draft stage, against every framework that applies, is what turns several rounds into one.

    Does CompliGUARD replace legal or regulatory advice?

    No. CompliGUARD gives you a compliance review and an audit trail; it does not give legal advice and is not a substitute for a regulatory consultant where you need one.

    Key takeaways

    1. Compliance is a roadblock only when it happens last; moved before publish, it stops holding campaigns back.
    2. Three questions test any set-up: who checks claims against the ARTG, who keeps the record, who owns the high-risk call.
    3. In-house teams have the context but often lack the structure — build the three answers in.
    4. With an agency, the advertiser still carries the claim, so ask whether they review against the Code before handing it back.
    5. A done-for-you partner removes the bottleneck only if the review is built into how they work, not bolted on at your end.

    Related questions

    Before you publish, check it.

    CompliGUARD reviews your marketing against TGA · AHPRA · FSANZ · ACCC in minutes, whoever creates it.
    Book a 20-minute call →

    Start a free review →

    Prefer marketing run for you with compliance built in? ClickFlow, our sister business →

    CompliGUARD provides compliance and creative marketing insights based on TGA, FSANZ, ACCC and AHPRA guidance as current at the time of review. The Therapeutic Goods Advertising Code is currently under formal review by the TGA (2025–26). CompliGUARD assessments reflect the current Code; guidance may be subject to change. This output does not constitute legal advice.